)
Beijing Wantai Biological Pharmacy Enterprise Co. (603392) investor relations material
Beijing Wantai Biological Pharmacy Enterprise Co. Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue grew 30.63% year-over-year to RMB 523.34 million, driven by strong HPV vaccine sales.
Net loss attributable to shareholders narrowed to RMB -42.98 million from RMB -52.78 million year-over-year.
Excluding non-recurring items, net loss reduced significantly, reflecting improved operational quality.
Financial highlights
Operating cash flow was negative at RMB -232.04 million, down from RMB -85.97 million year-over-year.
Basic and diluted EPS both at RMB -0.03, improved from RMB -0.04 year-over-year.
Gross margin and vaccine segment profitability improved, with the vaccine business turning profitable after several quarters.
Weighted average ROE improved by 0.07 percentage points to -0.36%.
Outlook and guidance
HPV vaccine expected to remain the core growth driver.
Diagnostic business showing signs of recovery after policy-driven headwinds, with mid-single-digit growth in Q1.
Laboratory automation projects expanding rapidly, with over 100% year-over-year growth.
- Revenue dropped 18.99% and net loss reached RMB -398 million amid vaccine market headwinds.603392
Q4 202521 Apr 2026 - H1 2024 revenue and profit plunged due to weak HPV vaccine sales, but diagnostics stayed stable.603392
Q2 202422 Dec 2025 - Revenue fell 38%, net loss ¥144M; diagnostics profitable, vaccines loss, further losses expected.603392
Q2 202522 Dec 2025 - Net loss of RMB 173.4 million amid revenue decline, but international vaccine sales surged.603392
Q3 202522 Dec 2025 - Q1 revenue dropped 46.76% and net loss reached RMB -52.78 million amid vaccine market headwinds.603392
Q1 202522 Dec 2025 - Revenue and profit fell sharply on weak vaccine sales, but diagnostics and R&D remained strong.603392
Q4 202422 Dec 2025 - Revenue and profit fell sharply on HPV vaccine headwinds, but diagnostics saw robust growth.603392
Q3 202422 Dec 2025
Next Beijing Wantai Biological Pharmacy Enterprise Co. earnings date
Next Beijing Wantai Biological Pharmacy Enterprise Co. earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)